Natera Inc (NTRA)

Trade NTRA now with
9/11/2020 12:55:50 AM Natera Prices Public Offering Of 4.17 Mln Shares At $60/Shr
8/27/2020 9:12:45 AM Natera Announces Collaborative Agreement With MGCC Of Massachusetts General Hospital
8/7/2020 9:06:10 AM Natera Files Patent Infringement Suit Against ArcherDX
6/18/2020 9:07:44 AM Natera : First Patient Enrolls In Both CIRCULATE-Japan And BESPOKE CRC Trials Using Signatera MRD Testing
6/17/2020 1:08:09 PM Natera Files Patent Suit Against Progenity
5/18/2020 9:06:00 AM Natera, Illumina Settle Patent Infringement Action
4/14/2020 12:14:03 AM Natera Prices $250 Million Convertible Senior Notes Due 2027
4/13/2020 7:13:20 AM Natera Proposes To Offer $250 Mln Of Convertible Senior Notes Due 2027
4/13/2020 7:05:56 AM Natera Expects Q1 Revenues Of $89 Mln - $91 Mln
1/27/2020 9:16:32 AM Natera Files Suit Against ArcherDX For Infringement Of U.S. Patent No. 10,538,814
1/15/2020 8:44:15 AM Natera Announces Agreement With National Cancer Center Japan To Launch CIRCULATE-IDEA Trial In Japan
1/13/2020 9:28:16 AM Natera Reports New Early Priority Date CfDNA Patent, Files Suit Against CareDx
1/9/2020 9:07:48 AM Natera To Evaluate Outcomes In 1,000 Signatera Patients With Stage II-III Colorectal Cancer
11/27/2019 8:22:35 AM Natera Announces Results Of A Study Published In The Journal Of Prenatal Diagnosis
10/16/2019 10:32:33 PM Natera Prices Underwritten Public Offering Of 5.71 Mln Shares At $35.00/shr
8/29/2019 9:21:06 AM Natera Appoints Rowan Chapman To Its Board